Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. by Lee, E, Palmer, DR, Flanagan, K, Reece, W, Odhiambo, K, Marsh, K, Pinder, M, Gravenor, M, Keitel, W, Kester, K, Diggs, C, Kaslow, D, Apostolopoulos, V, Ballou, W, Hill, A, Krzych, U, Plebanski, M

Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. by Ockenhouse, C, Sun, P, Lanar, D, Wellde, B, Hall, B, Kester, K, Stoute, J, Magill, A, Krzych, U, Farley, L, Wirtz, R, Sadoff, J, Kaslow, D, Kumar, S, Church, L, Crutcher, J, Wizel, B, Hoffman, S, Lalvani, A, Hill, A, Tine, J, Guito, K, de Taisne, C, Anders, R, Ballou, W